Is 40mg enoxaparin subcutaneously once daily sufficient to prevent clots in a patient with atrial fibrillation?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Enoxaparin 40 mg once daily is efficient for DVT prophylaxis but may not suffice for atrial fibrillation without further evaluation and potential dose adjustment.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN